Iressa Proven for Extended Survival Rates among Asians
Published: 2005-01-11 06:56:00
Updated: 2005-01-11 06:56:00
AstraZeneca Korea recently announced the results from the first-level intermediate analysis of ISEL (Iressa Survival Evaluation in Lung cancer) Study, an international clinical trial conducted against 1,692 patients with different racial backgrounds.
According to the analysis, the cancer patie...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
